Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting PI3K/Akt signaling in prostate cancer therapy.
J Cell Commun Signal. 2023 Sep;17(3):423-443. doi: 10.1007/s12079-022-00702-1. Epub 2022 Nov 11.
J Cell Commun Signal. 2023.
PMID: 36367667
Free PMC article.
Review.
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H, Hashemi M, Goharrizi MASB, Salimimoghadam S, Rashidi M, Taheriazam A, Samarghandian S.
Sadrkhanloo M, et al. Among authors: hejazi es.
Pharmacol Res. 2022 Aug;182:106311. doi: 10.1016/j.phrs.2022.106311. Epub 2022 Jun 15.
Pharmacol Res. 2022.
PMID: 35716914
Review.
Item in Clipboard
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S.
Entezari M, et al. Among authors: hejazi es.
Biomed Pharmacother. 2022 Oct;154:113609. doi: 10.1016/j.biopha.2022.113609. Epub 2022 Aug 27.
Biomed Pharmacother. 2022.
PMID: 36037786
Free article.
Review.
Item in Clipboard
Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects.
Hashemi M, Mirzaei S, Barati M, Hejazi ES, Kakavand A, Entezari M, Salimimoghadam S, Kalbasi A, Rashidi M, Taheriazam A, Sethi G.
Hashemi M, et al. Among authors: hejazi es.
Life Sci. 2022 Nov 15;309:120984. doi: 10.1016/j.lfs.2022.120984. Epub 2022 Sep 20.
Life Sci. 2022.
PMID: 36150461
Review.
Item in Clipboard
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
Mirzaei S, Paskeh MDA, Entezari M, Mirmazloomi SR, Hassanpoor A, Aboutalebi M, Rezaei S, Hejazi ES, Kakavand A, Heidari H, Salimimoghadam S, Taheriazam A, Hashemi M, Samarghandian S.
Mirzaei S, et al. Among authors: hejazi es.
Biomed Pharmacother. 2022 Dec;156:113860. doi: 10.1016/j.biopha.2022.113860. Epub 2022 Oct 20.
Biomed Pharmacother. 2022.
PMID: 36272267
Free article.
Review.
Item in Clipboard
siRNA and targeted delivery systems in breast cancer therapy.
Mirzaei S, Paskeh MDA, Entezari M, Bidooki SH, Ghaleh VJ, Rezaei S, Hejazi ES, Kakavand A, Behroozaghdam M, Movafagh A, Taheriazam A, Hashemi M, Samarghandian S.
Mirzaei S, et al. Among authors: hejazi es.
Clin Transl Oncol. 2023 May;25(5):1167-1188. doi: 10.1007/s12094-022-03043-y. Epub 2022 Dec 23.
Clin Transl Oncol. 2023.
PMID: 36562927
Review.
Item in Clipboard
The pharmacological and biological importance of EZH2 signaling in lung cancer.
Entezari M, Taheriazam A, Paskeh MDA, Sabouni E, Zandieh MA, Aboutalebi M, Kakavand A, Rezaei S, Hejazi ES, Saebfar H, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S.
Entezari M, et al. Among authors: hejazi es.
Biomed Pharmacother. 2023 Apr;160:114313. doi: 10.1016/j.biopha.2023.114313. Epub 2023 Feb 3.
Biomed Pharmacother. 2023.
PMID: 36738498
Free article.
Review.
Item in Clipboard
miRNAs as short non-coding RNAs in regulating doxorubicin resistance.
Mirzaei S, Paskeh MDA, Moghadam FA, Entezari M, Koohpar ZK, Hejazi ES, Rezaei S, Kakavand A, Aboutalebi M, Zandieh MA, Rajabi R, Salimimoghadam S, Taheriazam A, Hashemi M, Samarghandian S.
Mirzaei S, et al. Among authors: hejazi es.
J Cell Commun Signal. 2023 Dec;17(4):1181-1202. doi: 10.1007/s12079-023-00789-0. Epub 2023 Nov 29.
J Cell Commun Signal. 2023.
PMID: 38019354
Free PMC article.
Review.
Item in Clipboard
Cite
Cite